Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac

Detalhes bibliográficos
Autor(a) principal: Velasco, Eduardo D.
Data de Publicação: 2023
Outros Autores: Bouzas, Luis Fernando da Silva, Tabak, Daniel
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Brasileira de Cancerologia (Online)
Texto Completo: https://rbc.inca.gov.br/index.php/revista/article/view/3185
Resumo: Forty-seven patients were admitted to National Center for Bone Marrow Transplantation — CEMO in Rio de Janeiro. Fifty-seven Hickman-Broviac catheters were inserted by venous access. The mean duration of catheterization was 38days (range, 1-209days) fora total of 3104 catheter-days. Twenty-eight catheters (49.1 %) were removed after catheter-related infections; infection rate was 42.1 % and mortality rate 4.2%. After modification to a weekly catheter care and heparinization program assisted by nursing staff, the initial infection rate (45.2%) dropped to 20 % for the last 15 catheters evaluated. Neutropenia was nota risk factor for the development of sepsis related to the catheter. Gram-negative organisms were the predominant etiologic agents isolated during the infectious episodes (52 %). Enterobacter sp. and S. epidermidis were isolated with equal frequency and represented 48% of the isolates. Six microorganisms (24 %) were resistant to antibioties used during the infectious episodes. Four gram-negative organisms were resistant to amikacin and two, gram-positive, were resistant to oxacillin.
id INCA-1_809c811b54cde501f330113d4e8852b4
oai_identifier_str oai:rbc.inca.gov.br:article/3185
network_acronym_str INCA-1
network_name_str Revista Brasileira de Cancerologia (Online)
repository_id_str
spelling Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-BroviacCatéter Venoso Central de Longa PermanênciaInfecção Relacionada ao CatéterComplicaçõesMicrorganismos IsoladosCentral Venous CathetersCatheter-Related InfectionsComplicationsGram-Negative OrganismsForty-seven patients were admitted to National Center for Bone Marrow Transplantation — CEMO in Rio de Janeiro. Fifty-seven Hickman-Broviac catheters were inserted by venous access. The mean duration of catheterization was 38days (range, 1-209days) fora total of 3104 catheter-days. Twenty-eight catheters (49.1 %) were removed after catheter-related infections; infection rate was 42.1 % and mortality rate 4.2%. After modification to a weekly catheter care and heparinization program assisted by nursing staff, the initial infection rate (45.2%) dropped to 20 % for the last 15 catheters evaluated. Neutropenia was nota risk factor for the development of sepsis related to the catheter. Gram-negative organisms were the predominant etiologic agents isolated during the infectious episodes (52 %). Enterobacter sp. and S. epidermidis were isolated with equal frequency and represented 48% of the isolates. Six microorganisms (24 %) were resistant to antibioties used during the infectious episodes. Four gram-negative organisms were resistant to amikacin and two, gram-positive, were resistant to oxacillin. Quarenta e sete pacientes foram admitidos no Centro Nacional de Transplante de Medula Óssea - CEMO - do Rio de Janeiro, tendo sido introduzidos 57 cateteres de Hickman-Broviac. O período mediano de permanência dos cateteres foi de 38 dias, com uma variação de um a 209 dias e um total de 3.104 dias de catéter Vinte e oito cateteres (49,1 %) foram removidos devido a complicações relacionadas ao catéter. Vinte e quatro cateteres apresentaram complicações infecciosas, com uma taxa de infecção de 42,1 % e uma taxa de mortalidade de 4,2%. Após a introdução do manuseio e heparinização semanal dos cateteres pela equipe de enfermagem, a taxa inicial de infecção (45,2%) foi reduzida para 20% nos últimos 15 cateteres avaliados. A neutropenia não constituiu um fator de risco para o desenvolvimento de sepse relacionada ao catéter. Os microorganismos Gram-negativos predominaram como agentes etiológicos durante os episódios infeciosos (52%>). Isoladamente, a Enterobacter sp. E o S. epidermidis foram responsáveis por 48%) das infecções relacionadas ao catéter. Seis microorganismos (24%) foram resistentes aos antibióticos em uso durante o episódio infeccioso, sendo quatro bactérias Gram-negativas resistentes à amicacina, e duas Gram-positivas resistentes à oxacilina.INCA2023-08-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/318510.32635/2176-9745.RBC.1987v33n1.3185Revista Brasileira de Cancerologia; Vol. 33 No. 1 (1987): Mar.; 23-28Revista Brasileira de Cancerologia; Vol. 33 Núm. 1 (1987): mar.; 23-28Revista Brasileira de Cancerologia; v. 33 n. 1 (1987): mar.; 23-282176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/3185/2039https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessVelasco, Eduardo D.Bouzas, Luis Fernando da SilvaTabak, Daniel2023-08-04T19:54:44Zoai:rbc.inca.gov.br:article/3185Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-08-04T19:54:44Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false
dc.title.none.fl_str_mv Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
title Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
spellingShingle Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
Velasco, Eduardo D.
Catéter Venoso Central de Longa Permanência
Infecção Relacionada ao Catéter
Complicações
Microrganismos Isolados
Central Venous Catheters
Catheter-Related Infections
Complications
Gram-Negative Organisms
title_short Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
title_full Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
title_fullStr Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
title_full_unstemmed Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
title_sort Experiência do Centro Nacional de Transplante de Medula Óssea (CEMO) com uso de Cateteres tipo Hickman-Broviac
author Velasco, Eduardo D.
author_facet Velasco, Eduardo D.
Bouzas, Luis Fernando da Silva
Tabak, Daniel
author_role author
author2 Bouzas, Luis Fernando da Silva
Tabak, Daniel
author2_role author
author
dc.contributor.author.fl_str_mv Velasco, Eduardo D.
Bouzas, Luis Fernando da Silva
Tabak, Daniel
dc.subject.por.fl_str_mv Catéter Venoso Central de Longa Permanência
Infecção Relacionada ao Catéter
Complicações
Microrganismos Isolados
Central Venous Catheters
Catheter-Related Infections
Complications
Gram-Negative Organisms
topic Catéter Venoso Central de Longa Permanência
Infecção Relacionada ao Catéter
Complicações
Microrganismos Isolados
Central Venous Catheters
Catheter-Related Infections
Complications
Gram-Negative Organisms
description Forty-seven patients were admitted to National Center for Bone Marrow Transplantation — CEMO in Rio de Janeiro. Fifty-seven Hickman-Broviac catheters were inserted by venous access. The mean duration of catheterization was 38days (range, 1-209days) fora total of 3104 catheter-days. Twenty-eight catheters (49.1 %) were removed after catheter-related infections; infection rate was 42.1 % and mortality rate 4.2%. After modification to a weekly catheter care and heparinization program assisted by nursing staff, the initial infection rate (45.2%) dropped to 20 % for the last 15 catheters evaluated. Neutropenia was nota risk factor for the development of sepsis related to the catheter. Gram-negative organisms were the predominant etiologic agents isolated during the infectious episodes (52 %). Enterobacter sp. and S. epidermidis were isolated with equal frequency and represented 48% of the isolates. Six microorganisms (24 %) were resistant to antibioties used during the infectious episodes. Four gram-negative organisms were resistant to amikacin and two, gram-positive, were resistant to oxacillin.
publishDate 2023
dc.date.none.fl_str_mv 2023-08-04
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Artigos, Avaliado pelos pares
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3185
10.32635/2176-9745.RBC.1987v33n1.3185
url https://rbc.inca.gov.br/index.php/revista/article/view/3185
identifier_str_mv 10.32635/2176-9745.RBC.1987v33n1.3185
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rbc.inca.gov.br/index.php/revista/article/view/3185/2039
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv INCA
publisher.none.fl_str_mv INCA
dc.source.none.fl_str_mv Revista Brasileira de Cancerologia; Vol. 33 No. 1 (1987): Mar.; 23-28
Revista Brasileira de Cancerologia; Vol. 33 Núm. 1 (1987): mar.; 23-28
Revista Brasileira de Cancerologia; v. 33 n. 1 (1987): mar.; 23-28
2176-9745
reponame:Revista Brasileira de Cancerologia (Online)
instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron:INCA
instname_str Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
instacron_str INCA
institution INCA
reponame_str Revista Brasileira de Cancerologia (Online)
collection Revista Brasileira de Cancerologia (Online)
repository.name.fl_str_mv Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)
repository.mail.fl_str_mv rbc@inca.gov.br
_version_ 1797042234409877504